Your browser doesn't support javascript.
loading
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
Zecca, Chiara; Bellavia, G; Brambilla, L; Gutierrez, L P; Gerardi, C; Fiori, A M; Bernardini, L R; Camera, G; Disanto, G; Petrini, L; Perugini, J; Antozzi, C G; Torri Clerici, V; Bellino, A; Confalonieri, P A; Gobbi, C; Mantegazza, R E; Rossi, S.
Afiliación
  • Zecca C; Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland. chiara.zecca@eoc.ch.
  • Bellavia G; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy. chiara.zecca@eoc.ch.
  • Brambilla L; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Gutierrez LP; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Gerardi C; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Fiori AM; IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Bernardini LR; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Camera G; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Disanto G; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Petrini L; Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland.
  • Perugini J; Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland.
  • Antozzi CG; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Torri Clerici V; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Bellino A; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Confalonieri PA; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Gobbi C; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
  • Mantegazza RE; Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland.
  • Rossi S; Neuroimmunology and Neuromuscular Diseases Unit, IRCCS Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
CNS Drugs ; 32(7): 653-660, 2018 07.
Article en En | MEDLINE | ID: mdl-29949101
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Acetato de Glatiramer / Inmunosupresores Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2018 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Acetato de Glatiramer / Inmunosupresores Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2018 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Nueva Zelanda